Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home-based Non-invasive Brain Stimulation for Treatment-resistant Depression: Feasibility, Efficacy and Biomarker of Treatment Response

NCT05930509 is registered in ClinicalTrials.gov with Institut Guttmann as lead sponsor.

NCT NCT05930509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05930509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home-based Non-invasive Brain Stimulation for Treatment-resistant Depression: Feasibility, Efficacy and Biomarker of Treatment Response
Lead sponsor
Institut Guttmann
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2023
Completion date
December 31, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder